Ganga Pharmaceuticals Limited
BSE: GANGAPHARM
Prev Close
13.32
Open Price
14.6
Volume
8,000
Today Low / High
14.6 / 14.6
52 WK Low / High
9.25 / 27.1
Range
14 - 15
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 14.6, reflecting a change of 1.28 (9.60961%). The expected target range on the BSE is 14 - 15. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Ganga Pharmaceuticals Limited Graph
Ganga Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Ganga Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 14.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 14.60 | 14.75 | 13.27 - 16.22 |
| 14.89 | 11.91 - 17.87 | ||
| 15.04 | 10.53 - 19.55 | ||
| Bearish Scenario | 14.60 | 14.45 | 13.01 - 15.90 |
| 14.31 | 11.45 - 17.17 | ||
| 14.16 | 9.91 - 18.41 |
Overview of Ganga Pharmaceuticals Limited
ISIN
INE615T01017
Industry
Medical - Pharmaceuticals
Vol.Avg
761
Market Cap
86,307,900
Last Dividend
0
Official Website
IPO Date
DCF Diff
25.99
DCF
-13
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.64 Cr | 1.21 Cr | 1.42 Cr | 0.5394 | 0.00 Cr | 0.96 Cr | -0.16 Cr | 0.08 Cr | 0.10 | 0.32 Cr | 0.0300 |
| 2024-03-31 | 2.74 Cr | 1.25 Cr | 1.49 Cr | 0.5446 | 0.00 Cr | 0.85 Cr | 0.01 Cr | 0.05 Cr | 0.11 | 0.30 Cr | 0.0170 |
| 2023-03-31 | 2.59 Cr | 1.24 Cr | 1.35 Cr | 0.5208 | 0.00 Cr | 0.83 Cr | -0.05 Cr | 0.04 Cr | 0.10 | 0.30 Cr | 0.0152 |
| 2022-03-31 | 2.49 Cr | 1.28 Cr | 1.21 Cr | 0.4873 | 0.00 Cr | 0.09 Cr | -0.01 Cr | 0.04 Cr | 0.09 | 0.30 Cr | 0.0152 |
| 2021-03-31 | 2.37 Cr | 1.24 Cr | 1.14 Cr | 0.4792 | 0.00 Cr | 0.12 Cr | -0.02 Cr | 0.02 Cr | 0.05 | 0.27 Cr | 0.0086 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.30 Cr | 8.97 Cr | 1.84 Cr | 7.1314 Cr | 1.42 Cr | 1.12 Cr | 1.18 Cr | 0.66 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.6032 Cr |
| 2024-03-31 | 0.03 Cr | 8.65 Cr | 1.60 Cr | 7.0526 Cr | 1.36 Cr | 1.33 Cr | 1.24 Cr | 0.61 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.1955 Cr |
| 2023-03-31 | 0.03 Cr | 7.98 Cr | 2.53 Cr | 5.4501 Cr | 1.83 Cr | 1.80 Cr | 1.18 Cr | 0.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.8948 Cr |
| 2022-03-31 | 0.02 Cr | 8.00 Cr | 2.58 Cr | 5.4108 Cr | 1.93 Cr | 1.91 Cr | 1.15 Cr | 0.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.6856 Cr |
| 2021-03-31 | 0.01 Cr | 7.66 Cr | 2.29 Cr | 5.3729 Cr | 1.73 Cr | 1.71 Cr | 1.13 Cr | 0.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.6062 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.5772 Cr | 1.1813 Cr | -0.3315 Cr | -0.6759 Cr | 0.2726 Cr | 0.3024 Cr | -0.0987 Cr | 0.0947 Cr | -0.1629 Cr | 0.0000 Cr | 0.0591 Cr |
| 2024-03-31 | -1.2640 Cr | 0.1296 Cr | 1.1352 Cr | -1.2864 Cr | 0.0008 Cr | 0.0298 Cr | -0.0224 Cr | 0.0466 Cr | -0.2398 Cr | 0.0000 Cr | -0.0586 Cr |
| 2023-03-31 | -0.0399 Cr | 0.4923 Cr | -0.4439 Cr | -0.0547 Cr | 0.0086 Cr | 0.0290 Cr | -0.0148 Cr | 0.0531 Cr | -0.2571 Cr | 0.0000 Cr | -0.0328 Cr |
| 2022-03-31 | -0.2107 Cr | 0.1893 Cr | 0.0273 Cr | -0.2254 Cr | 0.0059 Cr | 0.0204 Cr | -0.0147 Cr | 0.0512 Cr | 0.2177 Cr | 0.0000 Cr | -0.0171 Cr |
| 2021-03-31 | -0.1755 Cr | 0.2762 Cr | -0.0979 Cr | -0.1923 Cr | 0.0028 Cr | 0.0145 Cr | -0.0168 Cr | 0.0374 Cr | 0.0812 Cr | 0.0000 Cr | -0.0933 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.33 Cr | 0.60 Cr | 0.73 Cr | 0.5506 | 0.00 Cr | 0.06 Cr | 0.11 | -0.02 Cr | 0.0415 |
| 2024-12-31 | 0.66 Cr | 0.30 Cr | 0.37 Cr | 0.5506 | 0.00 Cr | 0.03 Cr | 0.05 | 0.00 Cr | 0.0414 |
| 2024-09-30 | 0.66 Cr | 0.31 Cr | 0.35 Cr | 0.5281 | -0.06 Cr | 0.01 Cr | 0.03 | -0.06 Cr | 0.0184 |
| 2024-06-30 | 0.66 Cr | 0.31 Cr | 0.35 Cr | 0.5281 | -0.06 Cr | 0.01 Cr | 0.03 | -0.06 Cr | 0.0184 |
| 2024-03-31 | 0.71 Cr | 0.31 Cr | 0.39 Cr | 0.5570 | 0.37 Cr | 0.02 Cr | 0.03 | 0.00 Cr | 0.0215 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.30 Cr | 0.00 Cr | 0.30 Cr | 3.45 Cr | 1.18 Cr | 6.87 Cr | 0.66 Cr | 8.97 Cr | 1.84 Cr |
| 2024-12-31 | 0.30 Cr | 0.00 Cr | 0.30 Cr | 0.91 Cr | 1.18 Cr | 6.87 Cr | 0.66 Cr | 8.97 Cr | 1.84 Cr |
| 2024-09-30 | 0.48 Cr | 0.00 Cr | 0.48 Cr | 1.00 Cr | 1.17 Cr | 6.97 Cr | 0.60 Cr | 9.01 Cr | 1.93 Cr |
| 2024-06-30 | 0.48 Cr | 0.00 Cr | 0.48 Cr | 1.00 Cr | 1.17 Cr | 6.97 Cr | 0.60 Cr | 9.01 Cr | 1.93 Cr |
| 2024-03-31 | 0.03 Cr | 0.00 Cr | 0.03 Cr | 2.43 Cr | 1.24 Cr | 5.75 Cr | 0.61 Cr | 8.65 Cr | 1.60 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.06 Cr | 0.06 Cr | 0.03 Cr | -0.18 Cr | 0.30 Cr | 0.30 Cr | 0.00 Cr | -0.05 Cr | 0.02 Cr |
| 2024-12-31 | 0.03 Cr | 0.06 Cr | 0.03 Cr | -0.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.05 Cr | 0.02 Cr |
| 2024-09-30 | 0.01 Cr | -0.35 Cr | 0.56 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.36 Cr |
| 2024-06-30 | 0.01 Cr | -0.35 Cr | 0.56 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.36 Cr |
| 2024-03-31 | 0.02 Cr | -0.26 Cr | -0.31 Cr | 0.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.26 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: female
Year Born: 1965
Gender: male
Year Born: 1964
Gender: male
Year Born:
FAQs about Ganga Pharmaceuticals Limited
The CEO is Bharat Brijmohan Sharma.
The current price is ₹14.60.
The range is ₹9.25-27.1.
The market capitalization is ₹8.63 crores.
The P/E ratio is 107.68.
The company operates in the Healthcare sector.
Overview of Ganga Pharmaceuticals Limited (ISIN: INE615T01017) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹8.63 crores and an average daily volume of 761 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.